Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Higher Risks of Gastrointestinal Effects in Diabetic Patients In October 2023, The Journal of the American Medical Association(JAMA), examined adverse events in patients with diabetes associated with GLP-1 RA in a research letter called Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss where it concluded that studies have found increased risks of gastrointestinal adverse events, such as biliary disease, pancreatitis, bowel obstruction, and gastroparesis
If you find yourself craving the drug or needing to take higher doses to get the desired effects, its essential to seek medical help as soon as possible
In the 70s, other appetite suppressants appeared on the scene, recommended for safe (but limited) usage
Many people regain weight after stopping GLP-1 medication if they dont have sustainable diet, activity, and behaviour habits in place, so ongoing support is important
Patients should use a standardized reconstitution calculator and verify their math with their pharmacist before drawing the first dose from a new vial [14]
